MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.xjon.2025.09.002

Медицинская библиотека · JTCVS open · 2025

Resectable non-small cell lung cancer in women: A disease-specific entity?

Sewell Marisa, Boerner Thomas, Toumbacaris Nicolas, Tan Kay See, Choe Giye, Harrington Caitlin, Sihag Smita, Adusumilli Prasad S, Bott Matthew J, Downey Robert J, Huang James, Isbell James M, Park Bernard J, Rocco Gaetano, Gray Katherine, Rusch Valerie W, Jones David R, Molena Daniela

СтатьяПеревод пока не подготовлен

Аннотация

OBJECTIVE

There may be important sex-specific differences among patients with non-small cell lung cancer (NSCLC). Despite this, women are underrepresented in prospective clinical trials. We evaluated sex-specific differences in clinicopathologic and genetic factors and survival among patients with NSCLC.

METHODS

This is a single-center study at a high-volume dedicated cancer hospital. Patients with NSCLC who underwent complete surgical resection from 2010 to 2018 were included. Primary outcomes include cumulative incidence of recurrence and overall survival, stratified by sex.

RESULTS

Overall, 3452 patients were included; 2033 (59%) were women. More women than men were never-smokers (24% vs 13%; P < .001). Among patients who smoked, women had a significantly shorter pack-year history (30 vs 40 years; P < .001). Comorbid pulmonary (29% vs 35%; P < .001) and cardiac (53% vs 66%; P < .001) conditions were less common among women. Women had lower rates of clinical stage II or III disease (P < .001) and were more likely to have EGFR (28% vs 18%; P < .001) or KRAS (36% vs 29%; P = .018) mutations. Median overall survival among women was 11 years (95% confidence interval [CI], 10 years to not reached), compared with 7.9 years among men (95% CI, 7.5-8.6). This longer survival was sustained on multivariable analysis (hazard ratio, 0.86; 95% CI, 0.76-0.97; P = .013). Cumulative incidence of recurrence was not statistically different by sex (hazard ratio, 0.95; 95% CI, 0.82-1.09; P = .43).

CONCLUSIONS

Clinicopathologic and genetic factors and survival among patients with NSCLC differ on the basis of sex. NSCLC in women should be considered a disease-specific entity.

Для цитирования: Sewell Marisa, Boerner Thomas, Toumbacaris Nicolas, Tan Kay See, Choe Giye, Harrington Caitlin, Sihag Smita, Adusumilli Prasad S, Bott Matthew J, Downey Robert J, Huang James, Isbell James M, Park Bernard J, Rocco Gaetano, Gray Katherine, Rusch Valerie W, Jones David R, Molena Daniela. Resectable non-small cell lung cancer in women: A disease-specific entity?. JTCVS open. 2025. DOI: 10.1016/j.xjon.2025.09.002.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.